In line with this randomized clinical trial, we conducted 2-sample mendelian randomization using DIAGRAM and show genetic evidence of an association of IL18 inhibition on type 2 diabetes (odds ratio, 0.89 [95% CI, 0.81-0.99]; eMethods in the Supplement). The gene discussed is IL18; the disease is type 2 diabetes mellitus.